Motivators of enrolment in HIV vaccine trials: a review of HIV vaccine preparedness studies
Authors:
- 14 June 2011
- journal article
- review article
- Published by Taylor & Francis in AIDS Care
- Vol. 23 (11) , 1430-1447
Abstract
HIV vaccine preparedness studies (VPS) are important precursors to HIV vaccine trials. As well, they contribute to an understanding of motivators and barriers for participation in hypothetical HIV vaccine trials. Motivators can take the form of altruism and a desire for social benefits. Perceived personal benefits, including psychological, personal, and financial well-being, may also motivate participation. The authors performed a systematic review of HIV VPS using the Cochrane Database for Systematic Reviews, Medline, PubMed, Embase, and Google Scholar. The authors independently searched the literature for individual HIV VPS that examined motivators of participation in a hypothetical HIV vaccine trial, using the same search strategy. As the denominators employed in the literature varied across studies, the denominators were standardized to the number of respondents per survey item, regardless of their willingness to participate (WTP) in an HIV vaccine trial. The authors retrieved eight studies on social benefits (i.e., altruism) and 11 studies on personal benefits conducted in the Organization for Economic Co-operation and Development (OECD) countries, as well as 19 studies on social benefits and 20 studies on personal benefits in the non-OECD countries. Various different forms of altruism were found to be the major motivators for participation in an HIV vaccine trial in both the OECD and the non-OECD countries. In a large number of studies, protection from HIV was cited as a personal motivator for participation in a hypothetical HIV vaccine trial in the OECD and the non-OECD countries. Knowledge of motivators can inform and target recruitment for HIV vaccine trials, although it must be remembered that hypothetical motivators may not always translate into motivators in an actual vaccine trial.Keywords
This publication has 49 references indexed in Scilit:
- HIV vaccine preparedness studies in the non-organization for economic co-operation and development (non-OECD) countriesAIDS Care, 2009
- Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trialThe Lancet, 2008
- Knowledge and attitudes towards HIV vaccines among Soweto adolescentsBMC Research Notes, 2008
- The Role Familiarity With Science and Medicine Plays in Parents’ Decision Making About Enrolling a Child in Vaccine ResearchQualitative Health Research, 2007
- Adolescents and HIV Vaccine TrialsJournal of the International Association of Physicians in AIDS Care, 2005
- Determinants of Enrollment in a Preventive HIV Vaccine TrialJAIDS Journal of Acquired Immune Deficiency Syndromes, 2004
- Willingness to participate in HIV vaccine trials among a sample of men who have sex with men, with and without a history of commercial sex, Rio de Janeiro, BrazilAIDS Care, 2003
- Assessment of the Changing Willingness to Participate in Phase III HIV Vaccine Trials Among Men Who Have Sex With MenJAIDS Journal of Acquired Immune Deficiency Syndromes, 1997
- Willingness to participate in AIDS vaccine trials among high-risk populations in northern ThailandAIDS, 1995
- HIV-1 Virion-Cell Interactions: An Electrostatic Model of Pathogenicity and Syncytium FormationAIDS Research and Human Retroviruses, 1994